Vanguard Capital Management
ANGO icon

Vanguard Capital Management’s AngioDynamics ANGO Stock Holding History

Vanguard Capital Management’s Portfolio ANGO Stock Details ANGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$22M Sell
1,694,716
-32,104
-2% -$365K ﹤0.01% 2391
2026
Q1 		$19.6M Buy
+1,726,820
New +$18.7M ﹤0.01% 2354

Other funds holding ANGO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
SFM
Systematic Financial Management Teaneck, New Jersey $5.02B AUM 66.06% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
RA
Royce & Associates New York $12.4B AUM 64.17% 1-Year Est. Return
BH
Broadfin Holdings Melville, New York $23.7M AUM
WCM
Weber Capital Management San Francisco, California $118M AUM
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Vanguard Capital Management's ANGO Position: Q2 2026 in Review

Vanguard Capital Management reduced its AngioDynamics (ANGO) stake by 1.9% in Q2 2026, selling an estimated $365K and leaving 1,694,716 shares worth $22M. The position accounts for ﹤0.01% of the portfolio, ranked #2391.

Vanguard Capital Management first reported a position in ANGO in Q1 2026 and has held it in 2 quarters since. 160 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • Vanguard Capital Management held 1,694,716 shares of AngioDynamics worth $22M as of Q2 2026.
  • Vanguard Capital Management sold 32,104 AngioDynamics shares in Q2 2026, an estimated $365K.
  • AngioDynamics made up ﹤0.01% of Vanguard Capital Management's portfolio in Q2 2026, its #2391 holding.
  • Vanguard Capital Management first reported a position in AngioDynamics in Q1 2026 and has held it in 2 quarters since.
  • 160 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on Vanguard Capital Management's 13F filing for Q2 2026, filed 13 Aug 2026.